Nonoccupational Postexposure Human Immunodeficiency Virus Prophylaxis Acceptance Following Sexual Assault

被引:8
|
作者
Moret, Jessica E. Draughon [1 ]
Hauda, William E., II [2 ]
Price, Bonnie [3 ]
Sheridan, Daniel J. [4 ]
机构
[1] Univ Calif Davis, Betty Irene Moore Sch Nursing, Clin Nursing, Davis, CA USA
[2] Inova Fairfax Hosp, Forens Assessment & Consultat Team, Falls Church, VA USA
[3] Bon Secours St Marys Hosp, Forens Nurse Examiner Program, Richmond, VA USA
[4] Barnes Jewish Coll, Goldfarb Sch Nursing, St Louis, MO USA
基金
美国国家卫生研究院;
关键词
forensic nursing; HIV; postexposure prophylaxis; rape; HIV; SURVIVORS; VICTIMS; INJURY; CARE;
D O I
10.1097/NNR.0000000000000122
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Background: Nonoccupational postexposure prophylaxis (nPEP) for HIV following sexual assault may decrease the likelihood of HIV transmission. Objective: The purpose of this exploratory chart review study was to examine factors associated with patients accepting post-sexual assault nPEP at three forensic nurse examiner programs in urban settings. Methods: Forensic nursing charts of patients presenting for acute sexual assault care were reviewed as part of a mixed-methods study. Results: Patients assaulted by more than one or an unknown number of assailants were over 12 times more likely to accept the offer of nPEP (adjusted odds ratio [aOR] = 12.66, 95% CI [2.77, 57.82]). In cases where no condom was used (aOR = 8.57, 95% CI [1.59, 46.10]) or when any injury to the anus or genitalia was noted (aOR = 4.10, 95% CI [1.57, 10.75]), patients were more likely to accept nPEP. Patients with any injury to the face or head were less likely to initiate nPEP (aOR = 0.32, 95% CI [0.11, 0.97]). Discussion: This study is an important first step in understanding factors associated with nPEP acceptance after sexual assault.
引用
收藏
页码:47 / 54
页数:8
相关论文
共 50 条
  • [21] Improving Emergency Access to Human Immunodeficiency Virus Prophylaxis for Patients Evaluated After Sexual Assault
    Saadatzadeh, Tirajeh
    Salas, Natalie M.
    Walraven, Carla
    Sarangarm, Preeyaporn
    Crandall, Cameron S.
    Crook, Joy
    Sarangarm, Dusadee
    Yaple, Charles
    Stafford, Amanda
    Wilson, Christopher G.
    Page, Kimberly
    Carvour, Martha L.
    JOURNAL FOR HEALTHCARE QUALITY, 2021, 43 (02) : 82 - 91
  • [22] Sexual Assault and HIV Postexposure Prophylaxis at an Urban African Hospital
    Muriuki, Eric Munene
    Kimani, Joshua
    Machuki, Zipporah
    Kiarie, James
    Roxby, Alison C.
    AIDS PATIENT CARE AND STDS, 2017, 31 (06) : 255 - 260
  • [23] Cost effectiveness of human immunodeficiency virus postexposure prophylaxis for healthcare workers
    Scheid, DC
    Hamm, RM
    Stevens, KW
    PHARMACOECONOMICS, 2000, 18 (04) : 355 - 368
  • [24] Human Immunodeficiency Virus Postexposure Prophylaxis for Medical Trainees on International Rotations
    Mohan, Shaulnie
    Sarfaty, Suzanne
    Hamer, Davidson H.
    JOURNAL OF TRAVEL MEDICINE, 2010, 17 (04) : 264 - 268
  • [25] Postexposure prophylaxis: an intervention to prevent human immunodeficiency virus infection in adolescents
    Olshen, E
    Samples, CL
    CURRENT OPINION IN PEDIATRICS, 2003, 15 (04) : 379 - 384
  • [26] Cost Effectiveness of Human Immunodeficiency Virus Postexposure Prophylaxis for Healthcare Workers
    Dewey C. Scheid
    Robert M. Hamm
    Kevin W. Stevens
    PharmacoEconomics, 2000, 18 : 355 - 368
  • [27] Evaluation of Pediatric HIV Postexposure Prophylaxis Guideline Following Child Sexual Assault in Western Australia
    Combs, Momoko
    Johnson, Alice
    Abbotsford, Joanne
    Bowen, Asha C.
    McLeod, Charlie
    Foley, David A.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2024, 43 (08) : 785 - 788
  • [28] Prophylaxis against possible human immunodeficiency virus exposure after nonoccupational needlestick injuries or sexual assaults in children and adolescents
    Babl, FE
    Cooper, ER
    Kastner, B
    Kharasch, S
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2001, 155 (06): : 680 - 682
  • [29] Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus
    Pinkerton, SD
    Martin, JN
    Roland, ME
    Katz, MH
    Coates, TJ
    Kahn, JO
    ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (01) : 46 - 54
  • [30] Post-exposure prophylaxis following sexual exposure to human immunodeficiency virus
    Derancourt, C
    Drobacheff, C
    Verraes, S
    Beguinot, I
    Bernard, P
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2000, 127 (01): : 122 - 124